TrialHaematologica2010

Evaluation of the (R)VAD+C regimen for the treatment of newly diagnosed mantle cell lymphoma. Combined results of two prospective phase II trials from the French GOELAMS group.

Rémy Gressin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.